Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
PulteGroup | PHM | Sep 30, 2024 | 143.53 | +0.25 |
Puma Biotechnology | PBYI | Sep 30, 2024 | 2.55 | -1.16 |
Pure Cycle | PCYO | Sep 30, 2024 | 10.77 | -0.92 |
Pure Storage A | PSTG | Sep 30, 2024 | 50.24 | +1.62 |
PureCycle Technologies | PCT | Sep 30, 2024 | 9.50 | -1.04 |
PureCycle Technologies Unit | PCTTU | Sep 30, 2024 | 11.01 | -4.68 |
Purefunds ISE Junior Silver [Sm | SILJ | Sep 30, 2024 | 12.89 | -2.86 |
PureTech Health ADR | PRTC | Sep 30, 2024 | 20.61 | -2.99 |
Purple Biotech ADR | PPBT | Sep 30, 2024 | 5.55 | +2.40 |
Purple Innovation | PRPL | Sep 30, 2024 | 0.99 | -2.59 |
Putnam Managed Municipal Income Trust | PMM | Sep 30, 2024 | 6.51 | +0.62 |
Putnam Master Intermediate Income Trust | PIM | Sep 30, 2024 | 3.39 | -0.59 |
Putnam Municipal Opportunities Trust | PMO | Sep 30, 2024 | 10.90 | +0.93 |
Putnam Premier Income Trust | PPT | Sep 30, 2024 | 3.73 | +1.36 |
PVH | PVH | Sep 30, 2024 | 100.83 | +0.40 |
Pyrophyte Acquisition | PHYT | Sep 30, 2024 | 11.54 | 0.00 |
Pyxis Oncology | PYXS | Sep 30, 2024 | 3.67 | +1.38 |
Pyxis Tankers | PXS | Sep 30, 2024 | 4.95 | -2.46 |
Pyxis Tankers Pref | PXSAP | Sep 30, 2024 | 25.08 | -0.01 |
Q2 | QTWO | Sep 30, 2024 | 79.77 | +0.91 |
Q32 Bio | QTTB | Sep 30, 2024 | 44.62 | -3.00 |
QCR | QCRH | Sep 30, 2024 | 74.03 | +2.35 |
QIAGEN | QGEN | Sep 30, 2024 | 45.57 | +0.73 |
Qifu Technology ADR | QFIN | Sep 30, 2024 | 29.81 | +0.78 |
Qilian International | BGM | Sep 30, 2024 | 7.99 | 0.00 |
Qilian International | QLI | Sep 30, 2024 | 5.41 | 0.00 |
QMMM | QMMM | Sep 30, 2024 | 6.22 | 0.00 |
Qomolangma Acquisition | QOMO | Sep 30, 2024 | 11.50 | 0.00 |
Qorvo | QRVO | Sep 30, 2024 | 103.30 | -0.29 |
QT Imaging | QTI | Sep 30, 2024 | 0.71 | -5.25 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.